Today: 7 February 2026
Subscribe
Browse Category

Investment Analysis News 7 December 2025

UiPath (PATH) Stock Soars to 52‑Week High on Earnings Beat and AI Deals – Latest News, Forecasts and Analysis as of December 7, 2025

UiPath (PATH) Stock Soars to 52‑Week High on Earnings Beat and AI Deals – Latest News, Forecasts and Analysis as of December 7, 2025

UiPath Inc. (NYSE: PATH), the enterprise automation and “agentic AI” specialist, has just staged one of the sharpest rebounds in large-cap software this year. After a blowout third quarter, a flurry of artificial intelligence partnerships, and a high‑profile collaboration with Veeva, UiPath stock has surged more than 60% in recent months and now trades near its 52‑week high. Trefis+1 As of the last trading session on December 5, 2025, PATH closed at $18.67, near an intraday high of $18.98, giving UiPath a market capitalization of roughly $9.9 billion and marking a fresh one‑year high for the shares. MarketBeat+2Morningstar+2 This article
7 December 2025
····
Kroger (KR) Stock Update: Earnings Shock, E‑Commerce Pivot and Fresh Price Targets – December 7, 2025

Kroger (KR) Stock Update: Earnings Shock, E‑Commerce Pivot and Fresh Price Targets – December 7, 2025

Kroger (NYSE: KR) investors have had a lively start to December. After reporting a headline quarterly loss driven by a massive e‑commerce write‑down, the company beat profit expectations, trimmed its sales outlook and sketched an aggressive reset of its online strategy. The stock sold off sharply on the news, but Wall Street’s view remains cautiously bullish, with double‑digit upside implied by most 12‑month price targets. ir.kroger.com+2Reuters+2 This article rounds up the latest KR stock news, forecasts and analysis as of December 7, 2025, and explains what it may mean for Kroger’s share price going into 2026. Where KR stock stands
7 December 2025
·····
Southwest Airlines Stock (LUV) Near 52‑Week High After Fine Waiver and Profit Cut: Outlook, Forecasts and Risks as of December 7, 2025

Southwest Airlines Stock (LUV) Near 52‑Week High After Fine Waiver and Profit Cut: Outlook, Forecasts and Risks as of December 7, 2025

Ticker: LUV – Coverage date: December 7, 2025 Southwest Airlines stock is back in the spotlight. As of the close on Friday, December 5, 2025, shares of Southwest Airlines Co. (NYSE: LUV) finished just under $38, near a new 52‑week high, after rallying roughly 20% over the past month and about 12–13% year to date.MarketBeat+1 The catch: this surge comes right after the airline cut its 2025 profit outlook because of a 43‑day U.S. government shutdown and higher fuel costs—and just as U.S. regulators waive an $11 million fine tied to Southwest’s infamous 2022 holiday meltdown.Reuters+1 Here’s a detailed look
7 December 2025
···
BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP stock is ending the first week of December in a strange but familiar place: cash is pouring out to shareholders, the share price is recovering, analysts are split, and the long‑term energy transition story is getting messier. As of the close on 5 December 2025, BP’s New York–listed ADRs (NYSE: BP) traded around $35.8 per share, while the London‑listed stock (LSE: BP.) changed hands at about 453p, putting the UK shares up roughly 18% over the past year.StockAnalysis+1 TradingView estimates BP’s dividend yield at about 5.4%, cementing its status as a high‑income name in the FTSE 100.TradingView Yet on
7 December 2025
····
Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Updated: December 7, 2025 Merck & Co., Inc. (NYSE: MRK) — the U.S. pharmaceutical company behind blockbuster cancer drug Keytruda and HPV vaccine Gardasil — has just wrapped up a busy early-December news cycle. The company closed a multi‑billion‑dollar debt offering, secured fresh regulatory wins in its cardiopulmonary and animal-health franchises, boosted its dividend, and simultaneously ran into a new patent roadblock for its subcutaneous Keytruda injection in Germany. PR Newswire+4Wikipedia+4Stock Titan+4 Against that backdrop, MRK stock is trading near the top of its 52‑week range, and Wall Street is sharpening its forecasts for 2026 and beyond. MRK stock price
7 December 2025
·····
Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

As of 7 December 2025, Upstart Holdings (NASDAQ: UPST) sits right back in the market’s spotlight. The AI-powered consumer lender has delivered its strongest growth in years, secured multi‑billion‑dollar funding lines, and returned to GAAP profitability – yet its stock remains volatile, heavily shorted, and hotly debated on Wall Street. AlphaSense+1 This article rounds up the latest Upstart stock news, earnings, forecasts and analysis as of December 7, 2025, for readers tracking UPST on Google News and Discover. Upstart (UPST) stock price today: volatile AI lender with high short interest Upstart closed at about $46.75 per share in recent trading,
7 December 2025
·····
Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Updated December 7, 2025 – for information only, not investment advice. Novo Nordisk stock today: from market darling to turnaround story Novo Nordisk (NYSE: NVO), the Danish giant behind GLP‑1 blockbusters Wegovy and Ozempic, has gone from Europe’s most valuable listed company to a bruised turnaround story in 2025. For investors, NVO has abruptly shifted from a “can do no wrong” growth icon to a complex mix of structural strengths (dominant GLP‑1 franchise, deep pipeline, global reach) and cyclical headaches (pricing pressure, competition, R&D setbacks). The Alzheimer’s shock: EVOKE and EVOKE+ miss their goal The biggest single blow of 2025
7 December 2025
·····
Rivian (RIVN) Stock Forecast for December 2025: Recall Fallout, AI Day Hype and Volkswagen Deal Shape the 2026 Outlook

Rivian (RIVN) Stock Forecast for December 2025: Recall Fallout, AI Day Hype and Volkswagen Deal Shape the 2026 Outlook

As of the close on Friday, December 5, 2025, Rivian Automotive (NASDAQ: RIVN) stock traded around $17.95, just below a new 52‑week high of $18.17, giving the EV maker a market value of roughly $21.5 billion.MarketBeat+1 That price is 30–45% higher than a year ago, even after a major recall of nearly 35,000 electric delivery vans and multiple rounds of layoffs, but still about 90% below its post‑IPO peak.24/7 Wall St.+1 Here’s how the latest news, forecasts and analyses as of December 7, 2025 stack up for RIVN stock. Rivian stock today: price action and sentiment MarketBeat’s forecast page shows
7 December 2025
······
GE Stock in December 2025: Latest News, Analyst Forecasts and Valuation After the Pullback

GE Stock in December 2025: Latest News, Analyst Forecasts and Valuation After the Pullback

As of December 7, 2025, GE Aerospace (NYSE: GE) — the company that now carries the legacy General Electric ticker — is coming off a sharp rally, a strong earnings beat, and a brief earnings‑season hangover in its share price. The stock has become one of the most closely watched industrial names on Wall Street, helped by its focused aerospace portfolio and a flurry of fresh analyst calls. This article walks through the latest price action, earnings, analyst forecasts, and valuation signals around GE stock as of early December 2025. GE stock today: price snapshot and recent performance GE Aerospace
7 December 2025
···
C3.ai (AI) Stock News Today: Mixed Rebound After Q2 2026 Earnings, HHS Deal and Conflicting Analyst Targets

C3.ai (AI) Stock News Today: Mixed Rebound After Q2 2026 Earnings, HHS Deal and Conflicting Analyst Targets

Updated: December 7, 2025 Key Takeaways 1. How C3.ai Stock Has Traded Around December 6, 2025 C3.ai’s share price has been volatile into early December: Real‑time data as of the latest trade shows the stock around $15.08 with a market cap near $2.1 billion.SoFi Bottom line on price action: Into the weekend of December 6–7, C3.ai is in short‑term rebound mode but still in a long‑term drawdown, trading at only a fraction of its AI‑hype peak. 2. Q2 FY 2026 Results: Revenue Down, Bookings Up, Losses Deepen C3.ai reported fiscal Q2 2026 results (quarter ended October 31, 2025) after the
7 December 2025
·····
Figma (FIG) Stock Forecast: AI Growth, Insider Selling and Lawsuit Risks – December 2025 Update

Figma (FIG) Stock Forecast: AI Growth, Insider Selling and Lawsuit Risks – December 2025 Update

Figma’s blockbuster 2025 IPO has quickly turned into one of the year’s most dramatic tech stock roller coasters. As of the close on December 5, 2025, Figma Inc. (NYSE: FIG) trades just under $38 per share, well below its post-IPO peak of about $143, but still above its $33 IPO price. MarketWatch+1 Since 6 December 2025 is a Saturday, the latest full trading data comes from Friday’s session, along with news and analysis published through the weekend. Here’s a deep dive into what’s happening with Figma stock right now: price action, AI-fueled growth, a new class-action lawsuit, waves of insider
7 December 2025
·····
MGM Resorts International (MGM) Stock Today: Big Buyers, Analyst Downgrades and 2026–2030 Forecasts on December 6, 2025

MGM Resorts International (MGM) Stock Today: Big Buyers, Analyst Downgrades and 2026–2030 Forecasts on December 6, 2025

MGM Resorts International (NYSE: MGM) has had a busy start to December, with fresh institutional money flowing in, a key Wall Street price target cut, and new property and digital initiatives on the Las Vegas Strip and beyond. All of this is hitting the tape as traders look for direction in one of the market’s most closely watched casino and resort stocks. As of the latest close on December 5, 2025, MGM Resorts stock ended at $36.07, up about 1.9% on the day, and sits between its 52‑week low of $25.30 and high of $41.32.MGM Resorts Investor Relations Recent technical
7 December 2025
····
1 … 203 204 205 206 207 … 282

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop